The Blue Eye submucosal injection agent has received FDA clearance and is now available in the U.S. The product, manufactured by Korean devicemaker the Standard Company, is used in endoscopic ...
The electronic databases searched included: PubMed/MEDLINE, Cochrane Central Register of Controlled Trials (Central) and Web of Science until June 2015. There was no restriction to language and the ...
SAN DIEGO--(BUSINESS WIRE)--Aries Pharmaceuticals, Inc. (Aries) today announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable ...
Active ingredient: Dextranomer microspheres 50 mg/mL, sodium hyaluronate 15 mg/mL; gel for submucosal injection. Indication: Treatment of fecal incontinence in patients who have failed conservative ...
SAN DIEGO--(BUSINESS WIRE)--Aries Pharmaceuticals, Inc. (Aries), a specialty pharmaceutical company commercializing best-in-class gastroenterology products, shared positive results of the first ...
Valeant announced that the FDA has issued clearance for Restylane Silk Injectable Gel with 0.3% Lidocaine, a submucosal implant for lip augmentation and dermal implantation for correction of perioral ...
Here’s what you should know. 1. Eleview allows providers to remove polyps, adenomas, early stage cancers and other lesions in the gastrointestinal tract. 2. Cosmo Pharmaceuticals developed Eleview.
LAVAL, Quebec, Jun 16, 2014 (Canada NewsWire via COMTEX) -- Valeant Pharmaceuticals International, Inc. VRX -1.55% CA:VRX -1.58% today announced that that the U.S. Food and Drug Administration (FDA) ...
The figure was derived from‘International consensus on the management of large (≥20 mm) non-pedunculated colorectal polyps: A World Endoscopy Organisation Delphi study’; Djinbachian et al, 2023; Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback